180 related articles for article (PubMed ID: 6826485)
1. In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus.
Foldes M; Munro R; Sorrell TC; Shanker S; Toohey M
J Antimicrob Chemother; 1983 Jan; 11(1):21-6. PubMed ID: 6826485
[TBL] [Abstract][Full Text] [Related]
2. Novobiocin and rifampicin in combination against methicillin-resistant Staphylococcus aureus: an in-vitro comparison with vancomycin plus rifampicin.
Walsh TJ; Auger F; Tatem BA; Hansen SL; Standiford HC
J Antimicrob Chemother; 1986 Jan; 17(1):75-82. PubMed ID: 3633267
[TBL] [Abstract][Full Text] [Related]
3. In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus.
Drugeon HB; Caillon J; Juvin ME
J Antimicrob Chemother; 1994 Dec; 34(6):899-907. PubMed ID: 7730233
[TBL] [Abstract][Full Text] [Related]
4. The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus.
Moorhouse EC; Mulvihill TE; Jones L; Mooney D; Falkiner FR; Keane CT
J Antimicrob Chemother; 1985 Mar; 15(3):291-5. PubMed ID: 3158632
[TBL] [Abstract][Full Text] [Related]
5. In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus.
Grohs P; Kitzis MD; Gutmann L
Antimicrob Agents Chemother; 2003 Jan; 47(1):418-20. PubMed ID: 12499229
[TBL] [Abstract][Full Text] [Related]
6. Methicillin- and gentamicin-resistant Staphylococcus aureus: susceptibility to fosfomycin, cefamandole, N-formimidoyl-thienamycin, clindamycin, fusidic acid and vancomycin.
Graninger W; Leitha T; Breyer S; Francesconi M; Lenz K; Georgopoulos A
Drugs Exp Clin Res; 1985; 11(1):23-7. PubMed ID: 3869801
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
Ishag AJ; Durgham SM; Shibl AM
Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333
[TBL] [Abstract][Full Text] [Related]
8. In-vitro activity of ciprofloxacin combined with either fusidic acid or rifampicin against Staphylococcus aureus.
Røder BL; Gutschik E
J Antimicrob Chemother; 1989 Mar; 23(3):347-52. PubMed ID: 2732119
[TBL] [Abstract][Full Text] [Related]
9. Differences in ability of cell-wall antibiotics to suppress emergence of rifampicin resistance in Staphylococcus aureus.
Eng RH; Smith SM; Buccini FJ; Cherubin CE
J Antimicrob Chemother; 1985 Feb; 15(2):201-7. PubMed ID: 3845078
[TBL] [Abstract][Full Text] [Related]
10. Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and -resistant Staphylococcus aureus.
Bayer AS; Morrison JO
Antimicrob Agents Chemother; 1984 Aug; 26(2):220-3. PubMed ID: 6567464
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus.
Guenthner SH; Wenzel RP
Antimicrob Agents Chemother; 1984 Aug; 26(2):268-9. PubMed ID: 6237606
[TBL] [Abstract][Full Text] [Related]
12. Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus.
O'Neill AJ; Cove JH; Chopra I
J Antimicrob Chemother; 2001 May; 47(5):647-50. PubMed ID: 11328777
[TBL] [Abstract][Full Text] [Related]
13. In-vitro synergy testing of triple antibiotic combinations against Staphylococcus epidermidis isolates from patients with endocarditis.
Yu VL; Zuravleff JJ; Bornholm J; Archer G
J Antimicrob Chemother; 1984 Oct; 14(4):359-66. PubMed ID: 6501129
[TBL] [Abstract][Full Text] [Related]
14. In-vitro effects of vancomycin and rifampicin, alone and in combination, against methicillin-sensitive and methicillin-resistant staphylococci.
Varaldo PE; Debbia E; Schito GC
J Antimicrob Chemother; 1984 Dec; 14 Suppl D():35-41. PubMed ID: 6569872
[TBL] [Abstract][Full Text] [Related]
15. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
Shibl AM; Ishag AH; Durgham SM
APMIS Suppl; 1988; 3():68-70. PubMed ID: 2972301
[TBL] [Abstract][Full Text] [Related]
16. Activity of eleven antimicrobial agents against methicillin-, methicillin- and rifampin-resistant Staphylococcus aureus.
Chokkavelu V; Chandrasekar P; Rolston K; LeFrock JL; Schell RF
Chemotherapy; 1984; 30(2):97-101. PubMed ID: 6559665
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods.
Jacqueline C; Caillon J; Le Mabecque V; Miegeville AF; Donnio PY; Bugnon D; Potel G
J Antimicrob Chemother; 2003 Apr; 51(4):857-64. PubMed ID: 12654769
[TBL] [Abstract][Full Text] [Related]
18. Gentamicin- and methicillin-resistant, clinical isolates of Staphylococcus aureus: comparative in vitro and in vivo efficacy of alternative antimicrobial drugs.
Traub WH; Spohr M; Bauer D
Chemotherapy; 1984; 30(2):102-12. PubMed ID: 6559664
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of daptomycin combinations with rifampicin, gentamicin, fosfomycin and fusidic acid against MRSA strains.
Aktas G; Derbentli S
J Glob Antimicrob Resist; 2017 Sep; 10():223-227. PubMed ID: 28735049
[TBL] [Abstract][Full Text] [Related]
20. Methicillin resistance in Staphylococcus aureus with particular reference to Victorian strains.
Harvey K; Pavillard R
Med J Aust; 1982 May; 1(11):465-7. PubMed ID: 7048040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
